Cargando…

Assessing loss to follow-up in the MObile Technology for Improved Family Planning (MOTIF) randomised controlled trial

BACKGROUND: Loss to follow-up (LTFU) in clinical trials is an important source of bias that can affect statistical power and generalisability of findings. The aim of this paper is to assess factors associated with LTFU in the MObile Technology for Improved Family Planning (MOTIF) trial in Cambodia a...

Descripción completa

Detalles Bibliográficos
Autores principales: Smith, Chris, Jarvis, Christopher, Free, Caroline
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5709838/
https://www.ncbi.nlm.nih.gov/pubmed/29191231
http://dx.doi.org/10.1186/s13063-017-2316-6
_version_ 1783282849847181312
author Smith, Chris
Jarvis, Christopher
Free, Caroline
author_facet Smith, Chris
Jarvis, Christopher
Free, Caroline
author_sort Smith, Chris
collection PubMed
description BACKGROUND: Loss to follow-up (LTFU) in clinical trials is an important source of bias that can affect statistical power and generalisability of findings. The aim of this paper is to assess factors associated with LTFU in the MObile Technology for Improved Family Planning (MOTIF) trial in Cambodia and compare how the result might have varied using different analytical methods. METHODS: Follow-up in the MOTIF trial was 86% at 4 months and 66% at 12 months. For the primary analysis, we undertook a complete case analysis, similar to the approach used in similar trials of interventions delivered by mobile phone to increase contraception use. We conducted an exploratory analysis and found that factors associated with LTFU were young age, lower socio-economic status, not planning to use post-abortion contraception, availability of phone credit and not providing additional contact numbers. We then undertook two analyses to estimate the effect of the intervention on the primary outcome at 4 and 12 months for comparison with the complete case analysis. First, we undertook multiple imputation, and second we conducted an analysis treating all participants’ LTFU as non-users of contraception. RESULTS: Using multiple imputation, we found that the risk ratio was slightly increased at 4 months and slightly decreased at 12 months compared with the complete case analysis. When counting all participants’ LTFU as non-users of contraception, we observed that, compared with the complete case analysis, the risk ratio was slightly decreased at 4 months and slightly increased at 12 months. Despite the changes in the risk ratio, use of the different analytical methods did not result in an effect using the complete case analysis becoming statistically significant or vice versa. CONCLUSION: Future studies assessing contraception use might anticipate increased attrition amongst younger participants, those of lower socio-economic status or those who do not provide additional contact details. Attrition could be reduced by collecting as many contact details as possible, by providing incentives and possibly by enhanced counselling to groups at higher risk of LTFU on recruitment. Multiple imputation should be considered in addition to complete case analysis if LTFU not missing at random is expected or observed. TRIAL REGISTRATION: ClinicalTrials.gov, NCT01823861. Registered on 30 March 2013.
format Online
Article
Text
id pubmed-5709838
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-57098382017-12-06 Assessing loss to follow-up in the MObile Technology for Improved Family Planning (MOTIF) randomised controlled trial Smith, Chris Jarvis, Christopher Free, Caroline Trials Commentary BACKGROUND: Loss to follow-up (LTFU) in clinical trials is an important source of bias that can affect statistical power and generalisability of findings. The aim of this paper is to assess factors associated with LTFU in the MObile Technology for Improved Family Planning (MOTIF) trial in Cambodia and compare how the result might have varied using different analytical methods. METHODS: Follow-up in the MOTIF trial was 86% at 4 months and 66% at 12 months. For the primary analysis, we undertook a complete case analysis, similar to the approach used in similar trials of interventions delivered by mobile phone to increase contraception use. We conducted an exploratory analysis and found that factors associated with LTFU were young age, lower socio-economic status, not planning to use post-abortion contraception, availability of phone credit and not providing additional contact numbers. We then undertook two analyses to estimate the effect of the intervention on the primary outcome at 4 and 12 months for comparison with the complete case analysis. First, we undertook multiple imputation, and second we conducted an analysis treating all participants’ LTFU as non-users of contraception. RESULTS: Using multiple imputation, we found that the risk ratio was slightly increased at 4 months and slightly decreased at 12 months compared with the complete case analysis. When counting all participants’ LTFU as non-users of contraception, we observed that, compared with the complete case analysis, the risk ratio was slightly decreased at 4 months and slightly increased at 12 months. Despite the changes in the risk ratio, use of the different analytical methods did not result in an effect using the complete case analysis becoming statistically significant or vice versa. CONCLUSION: Future studies assessing contraception use might anticipate increased attrition amongst younger participants, those of lower socio-economic status or those who do not provide additional contact details. Attrition could be reduced by collecting as many contact details as possible, by providing incentives and possibly by enhanced counselling to groups at higher risk of LTFU on recruitment. Multiple imputation should be considered in addition to complete case analysis if LTFU not missing at random is expected or observed. TRIAL REGISTRATION: ClinicalTrials.gov, NCT01823861. Registered on 30 March 2013. BioMed Central 2017-12-01 /pmc/articles/PMC5709838/ /pubmed/29191231 http://dx.doi.org/10.1186/s13063-017-2316-6 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Commentary
Smith, Chris
Jarvis, Christopher
Free, Caroline
Assessing loss to follow-up in the MObile Technology for Improved Family Planning (MOTIF) randomised controlled trial
title Assessing loss to follow-up in the MObile Technology for Improved Family Planning (MOTIF) randomised controlled trial
title_full Assessing loss to follow-up in the MObile Technology for Improved Family Planning (MOTIF) randomised controlled trial
title_fullStr Assessing loss to follow-up in the MObile Technology for Improved Family Planning (MOTIF) randomised controlled trial
title_full_unstemmed Assessing loss to follow-up in the MObile Technology for Improved Family Planning (MOTIF) randomised controlled trial
title_short Assessing loss to follow-up in the MObile Technology for Improved Family Planning (MOTIF) randomised controlled trial
title_sort assessing loss to follow-up in the mobile technology for improved family planning (motif) randomised controlled trial
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5709838/
https://www.ncbi.nlm.nih.gov/pubmed/29191231
http://dx.doi.org/10.1186/s13063-017-2316-6
work_keys_str_mv AT smithchris assessinglosstofollowupinthemobiletechnologyforimprovedfamilyplanningmotifrandomisedcontrolledtrial
AT jarvischristopher assessinglosstofollowupinthemobiletechnologyforimprovedfamilyplanningmotifrandomisedcontrolledtrial
AT freecaroline assessinglosstofollowupinthemobiletechnologyforimprovedfamilyplanningmotifrandomisedcontrolledtrial